Menu Search
Equities

Cross Country Healthcare Inc

XXY:BER

Cross Country Healthcare Inc

Actions
  • Price (EUR)9.80
  • Today's Change-1.50 / -13.27%
  • Shares traded--
  • 1 Year change-43.02%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 20:40 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Cross Country Healthcare Inc's revenues fell -28.04%from 2.81bn to 2.02bn. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a -61.46% reduction in net income from 188.46m to 72.63m.
Gross margin21.33%
Net profit margin0.54%
Operating margin1.11%
Return on assets1.24%
Return on equity1.87%
Return on investment1.62%
More ▼

Cash flow in USDView more

In 2023, Cross Country Healthcare Inc increased its cash reserves by 374.31%, or 13.49m. The company earned 248.50m from its operations for a Cash Flow Margin of 12.30%. In addition the company used 13.78m on investing activities and also paid 221.24m in financing cash flows.
Cash flow per share0.7765
Price/Cash flow per share12.69
Book value per share13.15
Tangible book value per share7.63
More ▼

Balance sheet in USDView more

Cross Country Healthcare Inc uses little or no debt in its capital structure.
Current ratio3.07
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.